33 results
S-3ASR
EX-1.2
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
30 Sep 22
Automatic shelf registration
4:17pm
and contractual obligations relating to the privacy and security of IT Systems and Personal Data (“Data Protection Laws”) and to the protection
425
tahoe5oqjsb 7mf7yk
24 Mar 22
Business combination disclosure
9:09am
8-K
EX-2.2
hlorp6021
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
7s33l1z2 hnuo3q4ii
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
8-K
EX-2.1
o6yaig 1d
13 Oct 20
Entry into a Material Definitive Agreement
8:44am
8-K
EX-10.2
f33jt97g
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-10.1
mumdfmvk11 43nv40
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
SC TO-T
EX-99
muuagsdtlnebvvzv
31 Aug 20
Third party tender offer statement
8:46am
SC TO-T
EX-99
p5m lcrlkofhmi
31 Aug 20
Third party tender offer statement
8:46am
SC TO-C
EX-2.1
fsstk112ko vrczd
10 Aug 20
Information about tender offer
9:50pm
8-K
EX-2.1
16g546u
10 Aug 20
Tender and Support Agreement
9:48pm